Historic day, says SII CEO Poonawalla as he gets Covishield jab

Tribune Web Desk

Updated At : 07:47 PM Jan 16, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Pune, January 16

As the COVID-19 inoculation drive rolled out across India on Saturday, Serum Institute of India CEO Adar Poonawalla joined the healthcare workers in getting the Covishield vaccine shot.

Poonawalla shared a small video of him receiving the jab on Twitter.

“I wish India & Sri @narendramodi ji great success in launching the world’s largest COVID vaccination roll-out. It brings me great pride that #COVISHIELD is part of this historic effort & to endorse its safety & efficacy, I join our health workers in taking the vaccine myself,” he tweeted.

Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by the Pune-based SII.

Earlier in the day, Prime Minister Narendra Modi launching the world’s largest vaccination drive against the pandemic. — PTI

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles